Research programme: tension-type headache therapeutics - NsExplorer
Latest Information Update: 16 Jul 2016
At a glance
- Originator NsExplorer
- Class Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Tension type headache
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tension-headache in Denmark
- 19 Nov 2003 Preclinical trials in Tension headache in Denmark (unspecified route)